Category Archives: Parkinson’s Treatment

Parkinsons disease is a degenerative illness of the nervous system that results in loss of intentional movement and impaired motor functioning. Parkinsons disease symptoms affects smooth, natural movements of the body, and can make it hard to perform everyday tasks like speaking properly, walking, swallowing and sleeping. With Parkinsons, the area of the brain that controls muscular movements receives less dopamine than usual. Dopamine is an important chemical necessary for not only coordinating proper body movements, but also things like learning, increasing motivation and regulating moods. This is one reason why depression and other mood changes often affect those with Parkinsons.What causes Parkinsons, and is it curable? There is no specific known cause, but some aggravating factors include exposure to certain chemicals and toxic water, plus inflammation of the brain. While there is no cure for Parkinsons (the condition is both chronic and progressive), there are medications available to boost dopamine in the brain and help manage symptoms. (1) A 2016 study by researchers at the University of Saskatchewan also found a possible way to stop the progression of Parkinsons. Researchers created caffeine-based chemical compounds which also contained nicotine, metformin and aminoindan that prevented the misfolding of alpha-synuclein, a protein … Continue reading →

In most newly diagnosed Parkinsons patients, the anxiety revolves around the effect that the disease will have on daily functioning. However it should be noted that most Parkinsons patients can quite comfortably manage with daily activities although there may be some level of difficulty. The symptoms in the initial stages of Parkinsons disease may be mild, but in the last two stages of the disease or the end stages, the symptoms become such that the person becomes totally unable to function without help. In this stage, the main difficulty is in maintaining balance and posture, so patients need assistance while standing and walking. Increase in tremor, rigidity (increased tone) and bradykinesia (slowness of movement) as the disease progresses make the performance of routine tasks difficult without help. Falls tend to occur more often. The patient is mobile at this stage but needs help to carry on with their daily tasks. At this stage of the disease, the patient is unable to stand or walk and constant nursing care is needed as they cannot function independently. A number of patients also suffer from dementia, depression or hallucinations, which further aggravates the situation. The end stages of Parkinsons disease can be extremely … Continue reading →

Parkinson's diseaseSynonymsParkinson disease, idiopathic or primary parkinsonism, hypokinetic rigid syndrome, paralysis agitans, shaking palsyIllustration of Parkinson's disease by William Richard Gowers, first published in A Manual of Diseases of the Nervous System (1886)SpecialtyNeurologySymptomsShaking, rigidity, slowness of movement, difficulty walking[1]ComplicationsDementia, depression, anxiety[2]Usual onsetAge over 60[1][3]CausesUnknown[4]Risk factorsPesticide exposure, head injuries[4]Diagnostic methodBased on symptoms[1]Differential diagnosisDementia with Lewy bodies, progressive supranuclear palsy, essential tremor, antipsychotic use[5]TreatmentMedications, surgery[1]MedicationL-DOPA, dopamine agonists[2]PrognosisLife expectancy ~ 10 years[2]Frequency6.2 million (2015)[6]Deaths117,400 (2015)[7] Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.[1] The symptoms generally come on slowly over time.[1] Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking.[1] Thinking and behavioral problems may also occur.[2] Dementia becomes common in the advanced stages of the disease.[2] Depression and anxiety are also common, occurring in more than a third of people with PD.[2] Other symptoms include sensory, sleep, and emotional problems.[1][2] The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".[4][8] The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors.[4] Those with a family member affected are more likely to get the disease themselves.[4] … Continue reading →

Supporting Canadians with Parkinson's Since 1965 What is Parkinson's Parkinsons is a complex disease and everyone experiences it differently. Discover more about its diagnosis, symptoms, treatments and progression. Learn how you and your family can live well with Parkinsons. What is Parkinson's Parkinsons is a complex disease and everyone experiences it differently. Discover more about its diagnosis, symptoms, treatments and progression. Learn how you and your family can live well with Parkinsons. Helping your care team deliver the best care possible. Access the Canadian Guidelines on Parkinsons Disease, online learning and other resources. It's hard to know where to begin once you've been diagnosed. Get help through our resources for those who have been newly diagnosed. Research holds the key to unlocking better treatments, improving quality of life and finding a cure. Learn about the Parkinson Canada Research Program and how Canadas scientists are making a difference with your support. Research holds the key to unlocking better treatments, improving quality of life and finding a cure. Learn about the Parkinson Canada Research Program and how Canadas scientists are making a difference with your support. Today is a new day. How will you be relentless in your quest to beat Parkinsons … Continue reading →

Supporting Canadians with Parkinson's Since 1965 What is Parkinson's Parkinsons is a complex disease and everyone experiences it differently. Discover more about its diagnosis, symptoms, treatments and progression. Learn how you and your family can live well with Parkinsons. What is Parkinson's Parkinsons is a complex disease and everyone experiences it differently. Discover more about its diagnosis, symptoms, treatments and progression. Learn how you and your family can live well with Parkinsons. Helping your care team deliver the best care possible. Access the Canadian Guidelines on Parkinsons Disease, online learning and other resources. It's hard to know where to begin once you've been diagnosed. Get help through our resources for those who have been newly diagnosed. Research holds the key to unlocking better treatments, improving quality of life and finding a cure. Learn about the Parkinson Canada Research Program and how Canadas scientists are making a difference with your support. Research holds the key to unlocking better treatments, improving quality of life and finding a cure. Learn about the Parkinson Canada Research Program and how Canadas scientists are making a difference with your support. Today is a new day. How will you be relentless in your quest to beat Parkinsons … Continue reading →

A new study adds to growing evidence linking Parkinson's disease (PD) with inflammatory bowel disease (IBD). Researchers at the Icahn School of Medicine at Mount Sinai in New York City found people with IBD are at a 28 percent higher risk of developing PD than those without IBD. The study, published in JAMA Neurology, also suggests taking a common IBD treatment known as anti-Tumor Necrosis Factor (anti-TNF) may reduce the risk of Parkinson's. IBD patients who received anti-TNF therapy were 78 percent less likely to develop PD compared with patients who didn't receive the treatment. Anti-TNF therapy blocks a protein that promotes inflammation. While the exact way in which PD develops among people with IBD is still unknown, PD is associated with inflammation and digestion problems. Some studies have suggested that PD may involve inflammation that begins in the intestine decades before progressing to the central nervous system. The new study's insights will allow for better screening for IBD patients for PD, since the onset of IBD usually begins decades before PD develops, the researchers wrote. The study, which included data from 144,018 people with IBD and 720,090 people without the disease, also offers evidence to support exploring anti-TNF therapy … Continue reading →

Swiss Medica clinic is aware that not all Parkinsons disease patients are the same and that their symptoms can vary drastically.Age, disease progression, medical history, gender, physical condition, medications consumed etc are all important factors we take into considerations.This is the reason why we alter a specific treatment plan for each individual and create a treatment plan unique to the given person. When you decide which treatment option you are going to choose Inpatient or Outpatient, for 5 or 12 days all that is left for you to do is to make the reservation in Swiss Medica Clinic. To confirm your reservation in Swiss Medica, it is necessary to pay the reservation fee. You can now do it online, using the PayPal method, and by following the simple instructions that you will find by clicking on BOOK NOW button. If you have any questions or concerns, please feel free to contact our customer service with a call to the number +38162256192. Read more from the original source: Parkinson's stem cell treatment, Parkinsons disease clinic … Continue reading →

Research Fact 1*: "A clinical comparison of Mucuna pruriens (available in our kit) and synthetic Levodopa- a conventional drug used to treat Parkinson's, showed Mucuna exhibiting significantly better anti-parkinsonian effects and behavioural benefits with no side effects in the patients." 1 *Individual results may vary from individual to individual, as is seen in all clinical trials. Despite this peer reviewed scientific research these herbs and homeopathies may or may not have been approved by the FDA in every single country as a treatment or cure for Parkinsons disease yet. Hence one is advised to see a Doctor licensed in their city and state and we may only advertise our product in such countries for Brain and Nerve Health presently. Generally Ayurveda is only accepted as medicine in India. Homeopathy is considered medicine in most parts of the world but can only be used for over the counter issues in USA. Imagine getting back the life you once had. Do you remember how free it felt? If reclaiming that freedom is your aim, then please realize that it is essential for you to read this page and apply it to your life without delay, because nature alone completes you in many … Continue reading →

This fall, the Montreal Neurological Institute and Hospital (The Neuro, at McGill University and the McGill University Health Centre) expects to introduce a previously unavailable form of treatment for Parkinsons disease patients. Although the treatment will be limited to patients who fulfill specific criteria, the treatment has been shown to be effective in Europe, where it has been available for more than a decade. The treatment involves administering the drug Duodopa (a combination of levodopa and carbidopa) directly into the patients small intestine via the stomach through a tube. The drugs dosage is controlled by a mini-pump weighing about half a kilogram that the patient wears at the waist. The body transforms levodopa to dopamine to increase the amount of dopamine in the brain. Parkinsons disease symptoms are linked to dopamine levels. Carbidopa helps to guide levodopa to the brain and also helps to avoid stomach upset and other undesirable side effects of levodopa. MORE: RESEARCH MAY LEAD TO FASTER DIAGNOSIS OF PTSD The benefit of the Duodopa treatment is that the patient gets the drug continuously and so avoids the kinds of fluctuations that can come when drugs are taken orally at intervals during the day. Some patients have … Continue reading →

Hauser RA, Grosset DG. [(123) I]FP-CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes. J Neuroimaging. 2011 Mar 16. [Medline]. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011 Jun. 26 Suppl 1:S1-58. [Medline]. Anderson P. More Evidence Links Pesticides, Solvents, With Parkinson's. Medscape Medical News. Available at http://www.medscape.com/viewarticle/804834. Accessed: June 11, 2013. Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013 May 28. 80(22):2035-41. [Medline]. Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, et al. Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women. Am J Epidemiol. 2012 Apr 13. [Medline]. Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology. 1985 Jul. 35(7):949-56. [Medline]. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, et al. Parkinson disease in twins: an etiologic study. JAMA. 1999 Jan 27. 281(4):341-6. [Medline]. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997 Jun 27. … Continue reading →